Purinergic signalling in the immune system. A brief update

Purinergic Signalling

Volumn 3, Issue 1-2, 2007, Pages 1-3

  Virgilio, Francesco ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33947700320     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-006-9048-5     Document Type: Editorial

References (9)

1. Burnstock G (2006) Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev 58:58-86
2. Di Virgilio F, Baricordi OR, Romagnoli R, Baraldi PG (2005) Leukocyte P2 receptors: A novel target for anti-inflammatory and anti-tumor therapy. Curr Drug Targets Cardiovasc Haematol Disord 5:85-99
3. Sitkovsky M, Lukashev D (2005) Regulation of immune cells by local-tissue oxygen tension: HIF1α and adenosine receptors. Nat Rev Immunol 5:712-721
4. 7 receptor: A key player in IL-1 processing and release. J Immunol 176:3877-3883
5. Ogura Y, Sutterwala FS, Flavell RA (2006) The inflammasome: First line of the immune response to cell stress. Cell 126:659-662
6. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237-241
7. Sutterwala FS, Ogura Y, Szczepanik M et al (2006) Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24:317-327
8. la Sala A, Ferrari D, Di Virgilio F et al (2003) Alerting and tuning the immune response by extracellular nucleotides. J Leukoc Biol 73:339-343
9. Sitkovsky MV, Ohta A (2005) The 'danger' sensors that STOP the immune response: The A2 adenosine receptors? Trends Immunol 26:299-304